COG AALL0434: A randomized trial testing nelarabine in newly diagnosed t-cell malignancy.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Kimberly P. Dunsmore, Stuart Winter, Meenakshi Devidas, Brent L. Wood, Natia Esiashvili, Nancy Eisenberg, Nikki Briegel, Robert J. Hayashi, Julie M Gastier-Foster, Andrew J Carroll, Nyla A. Heerema, Barbara Asselin, Karen R. Rabin, Patrick Zweidler-McKay, Elizabeth A. Raetz, Mignon L. Loh, Naomi J. Winick, William L. Carroll, Stephen Hunger
Institutions: Carilion Clinic, Children's Minnesota, University of Florida, University of Washington, Emory University, Winship Cancer Institute, University of New Mexico, Princess Margaret Hospital for Children, Washington University in St. Louis, Nationwide Children's Hospital, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, University of Rochester, ImmunoGen (United States), University of Utah, University of California, San Francisco, The University of Texas Southwestern Medical Center, NYU Langone Health, Children's Hospital of Philadelphia
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2889648694